These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. (18)F-DOPA PET/CT revealed synchronous neuroendocrine tumors in two sisters with MEN2A syndrome. Treglia G; Castaldi P; Rufini V Endocrine; 2013 Apr; 43(2):458-9. PubMed ID: 23229684 [No Abstract] [Full Text] [Related]
4. 18F-fluorodihydroxyphenylalanine in the diagnosis of neuroendocrine tumors. Minn H; Kemppainen J; Kauhanen S; Forsback S; Seppänen M PET Clin; 2014 Jan; 9(1):27-36. PubMed ID: 25029931 [TBL] [Abstract][Full Text] [Related]
5. Multiple endocrine neoplasia type 2A syndrome (MEN2A) and usefulness of 68Ga-DOTATATE PET/CT in this syndrome. Tuzcu SA; Pekkolay Z Ann Ital Chir; 2019; 90():497-503. PubMed ID: 30837349 [TBL] [Abstract][Full Text] [Related]
6. Role of (18) F-FDOPA PET/CT imaging in endocrinology. Santhanam P; Taïeb D Clin Endocrinol (Oxf); 2014 Dec; 81(6):789-98. PubMed ID: 25056984 [TBL] [Abstract][Full Text] [Related]
7. Use of Dexmedetomidine in a Parturient With Multiple Endocrine Neoplasia Type 2A Undergoing Adrenalectomy and Thyroidectomy: A Case Report. Faulkner AL; Swanson E; McLarney TL; Lee CY; Rebel A A A Pract; 2019 Mar; 12(5):136-140. PubMed ID: 30095445 [TBL] [Abstract][Full Text] [Related]
8. Adrenal tracer uptake by Noordzij W; Glaudemans AWJM; Schaafsma M; van der Horst-Schrivers ANA; Slart RHJA; van Beek AP; Kerstens MN Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1560-1566. PubMed ID: 31011769 [TBL] [Abstract][Full Text] [Related]
9. 123I-MIBG, 18F-DOPA and 18F-FDG in a patient with MEN2 syndrome and recurrent pheochromocytoma. Cuenca-Cuenca JI; Marín-Oyaga VA; Borrego-Dorado I; Navarro-González E; Martos-Martínez JM; Vázquez-Albertino R Rev Esp Med Nucl Imagen Mol; 2013; 32(4):263-5. PubMed ID: 23434017 [TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of normal and pathologic adrenal glands with 18F-FDOPA PET/CT: focus on pheochromocytomas. Moreau A; Giraudet AL; Kryza D; Borson-Chazot F; Bournaud C; Mognetti T; Lifante JC; Combemale P; Giammarile F; Houzard C Nucl Med Commun; 2017 Sep; 38(9):771-779. PubMed ID: 28704339 [TBL] [Abstract][Full Text] [Related]
11. Prospective comparison of (68)Ga-DOTATATE and (18)F-FDOPA PET/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases. Archier A; Varoquaux A; Garrigue P; Montava M; Guerin C; Gabriel S; Beschmout E; Morange I; Fakhry N; Castinetti F; Sebag F; Barlier A; Loundou A; Guillet B; Pacak K; Taïeb D Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1248-57. PubMed ID: 26637204 [TBL] [Abstract][Full Text] [Related]
12. MEN 1 and 2: the role of diagnostic imaging. Gollini P; Cataldi A; Fava C Radiol Med; 2004; 107(1-2):78-87. PubMed ID: 15031699 [TBL] [Abstract][Full Text] [Related]
13. 18F-FDOPA PET Compared With 123I-Metaiodobenzylguanidine Scintigraphy and 18F-FDG PET in Secreting Sporadic Pheochromocytoma. Lugat A; Drui D; Mirallié E; Kraeber-Bodéré F; Ansquer C Clin Nucl Med; 2019 Sep; 44(9):738-740. PubMed ID: 31306205 [TBL] [Abstract][Full Text] [Related]
15. Detection of hepatic metastasis from medullary thyroid cancer with Tc-99m-MIBI scintigraphy in a patient with Sipple's syndrome. Sato S; Okumura Y; Tamizu A; Maki K; Akaki S; Takeda Y; Kanazawa S; Hiraki Y Ann Nucl Med; 2001 Oct; 15(5):443-6. PubMed ID: 11758951 [TBL] [Abstract][Full Text] [Related]
16. (18)F-DOPA PET/CT and MRI: description of 12 histologically-verified pheochromocytomas. Magnaldi S; Mayerhoefer ME; Khameneh A; Schuetz M; Javor D; Mitterhauser M; Dudczak R; Hacker M; Karanikas G Anticancer Res; 2014 Feb; 34(2):791-5. PubMed ID: 24511014 [TBL] [Abstract][Full Text] [Related]
17. [Pheochromocytoma and multiple endocrine neoplasia type 2a]. Klein M; Payaslian S; Pascuccio M; Morón J Medicina (B Aires); 2003; 63(3):228. PubMed ID: 12876909 [No Abstract] [Full Text] [Related]